{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:37:05Z","timestamp":1783161425618,"version":"3.54.6"},"reference-count":48,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BLCTT"],"DOI":"10.2147\/blctt.s426588","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:55:32Z","timestamp":1700747732000},"page":"67-76","source":"Crossref","is-referenced-by-count":7,"title":["Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review"],"prefix":"10.2147","volume":"Volume 13","author":[{"given":"Nada","family":"Alsuhebany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congshan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Holovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11]]},"reference":[{"key":"ref1","volume-title":"Syed Ali Abutalib, Hematology","year":"2018"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/1471-2407-14-764","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/cncr.23608","volume":"113","author":"Zhou","year":"2008","journal-title":"Cancer"},{"key":"ref4","volume-title":"StatPearls [Internet]","year":"2020"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13046-017-0652-8","volume":"36","author":"Ye","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-6-24","volume":"6","author":"Alao","year":"2007","journal-title":"Mol Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/cncr.11096","volume":"97","author":"Romaguera","year":"2003","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/cncr.22715","volume":"109","author":"Ferrer","year":"2007","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1182\/blood-2009-08-236570","volume":"115","author":"Geisler","year":"2010","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/jcm10061207","volume":"10","author":"Bond","year":"2021","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41408-019-0209-5","volume":"9","author":"Kumar","year":"2019","journal-title":"Blood Cancer J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41375-020-01013-3","volume":"35","author":"Visco","year":"2021","journal-title":"Leukemia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/82_2015_478","volume":"393","author":"Corneth","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12272-019-01124-1","volume":"42","author":"Kim","year":"2019","journal-title":"Arch Pharm Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/blood-2013-02-482125","volume":"122","author":"Chang","year":"2013","journal-title":"Blood"},{"key":"ref21","unstructured":"Food and Drug Administration. Food and Drug Administration grants have accelerated the approval of zanubrutinib for mantle cell lymphoma. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma. Accessed November 20, 2020."},{"key":"ref22","unstructured":"BRUKINSA (Zanubrutinib) [prescribing information]. San Mateo, CA: BeiGene USA, Inc.; 2019."},{"key":"ref23","unstructured":"National Comprehensive Cancer Network (NCCN). B-cell lymphomas. Version 6; 2023. Available from: www.nccn.org. Accessed September 24, 2023."},{"key":"ref24","unstructured":"BRUKINSA (zanubrutinib) [package insert]. San Mateo, CA: BeiGene, Ltd; 2019."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/hon.2667","volume":"37","author":"Zou","year":"2019","journal-title":"Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"Abstract 832","DOI":"10.1182\/blood.V126.23.832.832","volume":"126","author":"Tam","year":"2015","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood.2019001160","volume":"134","author":"Tam","year":"2019","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-016-0313-y","volume":"9","author":"Wu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1182\/blood-2019-125488","volume":"134","author":"Handunnetti","year":"2019","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","volume":"26","author":"Cheah","year":"2015","journal-title":"Ann Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.3435","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1182\/blood.V124.21.78.78","volume":"124","author":"Balasubramanian","year":"2014","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"abstr 7570","DOI":"10.1200\/JCO.2016.34.15_suppl.7570","volume":"34","author":"Lenz","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41375-021-01123-6","volume":"35","author":"Estupinan","year":"2021","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40265-019-01252-4","volume":"80","author":"Sayed","year":"2020","journal-title":"Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1358\/dot.2020.56.8.3158047","volume":"56","author":"Weaver","year":"2020","journal-title":"Drugs Today"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1080\/10428194.2021.1929961","volume":"62","author":"Ou","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.3324\/haematol.2019.220590","volume":"105","author":"Flinsenberg","year":"2020","journal-title":"Haematologica"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1182\/bloodadvances.2020004074","volume":"5","author":"Tam","year":"2021","journal-title":"Blood Adv"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1182\/blood.2021014162","volume":"139","author":"Song","year":"2022","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/fon-2020-0794","volume":"17","author":"Dreyling","year":"2021","journal-title":"Future Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S1470-2045(22)00293-5","volume":"23","author":"Tam","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref43","unstructured":"Hillmen P, Eichhorst B, Brown JR, et al. First interim analysis of ALPINE study: results of a phase 3 randomized study of zanubrutinib vs ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma. EHA 2021 Virtual Congress. Abstract LB1900. June 11; 2021."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1182\/bloodadvances.2021005621","volume":"6","author":"Tam","year":"2022","journal-title":"Blood Adv"},{"key":"ref45","unstructured":"Lexicomp Online [online database]. Hudson, OH: Lexi-Comp; 2022."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.26736","volume":"97","author":"Tam","year":"2022","journal-title":"Am J Hematol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2352-3026(22)00320-9","volume":"10","author":"Shadman","year":"2023","journal-title":"Lancet Haematol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.18553\/JMCP.2022.28.4.390\/ASSET\/IMAGES\/SMALL\/FIG2.GIF","volume":"28","author":"Alrawashdh","year":"2022","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Blood and Lymphatic Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94642","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94642","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:55:37Z","timestamp":1700747737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/zanubrutinib-in-mantle-cell-lymphoma-management-a-comprehensive-review-peer-reviewed-fulltext-article-BLCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":48,"URL":"https:\/\/doi.org\/10.2147\/blctt.s426588","relation":{},"ISSN":["1179-9889"],"issn-type":[{"value":"1179-9889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}